Skip to main content

Animations

MJFF Publications

4081 - 4090 of 6396 Results
Title
Year
  • Year
  • 2017
  • 2018
  • 2018
  • 2021
  • 2021
  • 2018
  • 2017
  • 2025
  • 2011
  • 2018
  • Summary Details
    OPEN
    Title: Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.06.010
    Citation Count: 162
  • Summary Details
    OPEN
    Title: ELISA method to detect α-synuclein oligomers in cell and animal models
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0196056
    Citation Count: 74
  • Summary Details
    OPEN
    Title: The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-22814-8
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-x
    Citation Count: 251
  • Summary Details
    OPEN
    Title: GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-23795-4
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nsmb.3433
    Citation Count: 169
  • Summary Details
    OPEN
    Title: The bridge-like lipid transport protein VPS13C/PARK23 mediates ER–lysosome contacts following lysosome damage
    Journal Name: Nature Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41556-025-01653-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: 1
    DOI - Digital Object Identifier: 10.1038/emboj.2011.318
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-018-05892-0
    Citation Count: 434
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.